NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 09 12:53PM ET
0.6649
Dollar change
+0.0249
Percentage change
3.89
%
Index- P/E- EPS (ttm)-0.09 Insider Own17.12% Shs Outstand139.08M Perf Week-7.01%
Market Cap92.64M Forward P/E- EPS next Y-0.01 Insider Trans-75.40% Shs Float115.47M Perf Month-4.33%
Enterprise Value121.51M PEG- EPS next Q-0.01 Inst Own20.24% Short Float0.05% Perf Quarter46.15%
Income-11.99M P/S0.76 EPS this Y83.33% Inst Trans-78.18% Short Ratio0.27 Perf Half Y26.17%
Sales122.30M P/B2.11 EPS next Y25.00% ROA-12.64% Short Interest0.06M Perf YTD50.09%
Book/sh0.32 P/C17.06 EPS next 5Y- ROE-26.20% 52W High0.83 -20.13% Perf Year1.02%
Cash/sh0.04 P/FCF- EPS past 3/5Y-29.49% 27.73% ROIC-18.11% 52W Low0.33 100.88% Perf 3Y38.52%
Dividend Est.- EV/EBITDA- Sales past 3/5Y28.50% 12.64% Gross Margin58.18% Volatility8.18% 8.48% Perf 5Y-32.15%
Dividend TTM- EV/Sales0.99 EPS Y/Y TTM-498.66% Oper. Margin-6.17% ATR (14)0.06 Perf 10Y-98.22%
Dividend Ex-Date- Quick Ratio1.03 Sales Y/Y TTM20.81% Profit Margin-9.81% RSI (14)52.46 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.34 EPS Q/Q101.18% SMA202.73% Beta-0.19 Target Price1.75
Payout- Debt/Eq0.78 Sales Q/Q18.05% SMA505.93% Rel Volume0.35 Prev Close0.64
Employees232 LT Debt/Eq0.51 EarningsMay 12 AMC SMA20023.93% Avg Volume210.87K Price0.66
IPOJul 01, 2010 Option/ShortNo / Yes EPS/Sales Surpr.3588.75% 5.39% Trades Volume41,388 Change3.89%
Date Action Analyst Rating Change Price Target Change
Dec-05-23Initiated BTIG Research Buy $2
Nov-15-18Reiterated Maxim Group Buy $10 → $6
Feb-14-18Reiterated Maxim Group Buy $18 → $10
Today 07:28AM
Jul-08-25 09:01AM
08:00AM
May-28-25 08:00AM
May-12-25 04:05PM
08:00AM Loading…
May-06-25 08:00AM
Apr-23-25 08:00AM
Apr-16-25 08:05AM
Mar-06-25 03:05PM
Feb-28-25 08:00AM
Nov-12-24 04:05PM
Nov-11-24 08:00AM
Nov-07-24 10:45AM
Sep-23-24 07:00AM
Sep-18-24 06:00AM
07:20AM Loading…
Aug-08-24 07:20AM
07:10AM
07:05AM
Jul-25-24 08:30AM
May-22-24 04:35PM
May-16-24 05:00AM
May-15-24 04:05PM
May-08-24 08:30AM
Apr-30-24 05:00AM
Apr-02-24 11:19AM
01:13AM
Apr-01-24 07:00AM
Mar-21-24 04:05PM
Mar-07-24 04:05PM
Feb-26-24 04:05PM
02:01PM Loading…
Feb-20-24 02:01PM
Feb-05-24 08:00AM
Nov-10-23 03:41AM
Nov-09-23 04:44PM
08:25AM
07:00AM
Nov-02-23 04:05PM
Oct-23-23 04:05PM
Oct-12-23 04:05PM
Aug-10-23 04:15PM
Aug-02-23 02:28AM
Aug-01-23 07:00AM
Jul-28-23 03:56PM
Jul-25-23 04:05PM
Jul-07-23 08:00AM
Jul-03-23 07:27AM
May-18-23 08:00AM
May-09-23 02:59PM
May-04-23 07:00AM
Apr-27-23 08:00AM
Mar-07-23 11:19PM
07:00AM
Mar-03-23 08:00AM
Mar-01-23 09:15AM
Feb-28-23 08:00AM
Jan-09-23 08:00AM
Nov-21-22 08:00AM
Nov-03-22 07:00AM
Oct-27-22 08:00AM
Oct-11-22 08:00AM
Aug-31-22 08:00AM
Aug-24-22 08:00AM
Aug-04-22 07:00AM
Jul-28-22 08:00AM
May-05-22 08:00AM
May-02-22 08:00AM
Apr-28-22 08:30AM
Mar-15-22 08:00AM
Mar-08-22 07:00AM
Mar-01-22 08:30AM
Jan-04-22 08:00AM
Jan-03-22 08:00AM
Nov-12-21 07:00AM
Nov-05-21 08:30AM
Oct-19-21 08:00AM
Sep-07-21 08:00AM
Aug-05-21 07:00AM
Jul-29-21 04:05PM
Jun-18-21 10:46PM
May-11-21 07:15AM
07:05AM
07:00AM
May-06-21 04:05PM
May-04-21 08:30AM
Mar-03-21 05:21AM
Feb-26-21 04:05PM
12:48PM
Feb-25-21 08:30AM
Feb-24-21 07:15AM
07:00AM
Feb-22-21 08:30AM
Feb-17-21 08:30AM
Dec-07-20 08:30AM
Nov-27-20 07:07PM
Oct-29-20 07:00AM
Oct-22-20 04:05PM
Oct-20-20 09:30PM
09:30PM
08:30AM
Oct-06-20 07:00AM
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORBIMED ADVISORS LLC10% OwnerApr 10 '25Sale0.4273,114,59230,708,1290Apr 14 07:14 PM